Menopause
📧 Sign up to get email alerts when something new happens for Menopause.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-01-26FDA Approved: ANGELIQ — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved ANGELIQ—Supplemental Application for the Bayer HealthCare Pharmaceuticals Inc. product. The approval concerns the drospirenone …
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women [Phase 2]
Phase 2 trial evaluating the efficacy of ESTRATEST H.S. Tablets in relieving menopausal symptoms in estrogenized postmenopausal women.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Vilazodone for Menopausal Hot Flashes [NA]
This update reports the completion and posted results of a clinical trial evaluating vilazodone for menopausal hot flashes.
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Fat Distribution in Healthy Early Postmenopausal Women [Phase 4]
A Phase 4 clinical trial update sponsored by Bayer on fat distribution in healthy early postmenopausal women has completed.
-
FDA approval · 2014-12-19FDA Approved: ESTRADIOL — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an original application for a generic estradiol product from Mylan Pharmaceuticals.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-12-03Clinical Trial Update: Effects of Ospemifene on Pelvic Vascularity and Blood Flow
The clinical trial evaluating ospemifene's effects on pelvic vascularity and blood flow in menopause was withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Menopause and Meditation for Breast Cancer Survivors [Phase 1, Phase 2]
A clinical trial update indicates completion of Phase 1 and Phase 2 studies evaluating menopause and meditation for breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Isoflavones and Magnolia Extract in the Quality of Life in Menopausal Women
A completed clinical trial evaluating whether isoflavones and Magnolia extract affect quality of life in menopausal women.
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months
An observational study completed to assess bleeding events in postmenopausal women treated with Estradiol/NETA for 12 months.
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms. [Phase 3]
A Phase 3 safety and efficacy trial evaluating a drospirenone/estradiol combination for vasomotor symptoms in postmenopausal Chinese women h…
-
FDA approval · 2014-09-25FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Premarin Vaginal (conjugated estrogens) from Wyeth Pharmaceuticals (Pfizer) to modify the pr…
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Black Cohosh Extract for Treatment of Moderate to Severe Menopausal Symptoms [Phase 3]
A Phase 3 clinical trial is evaluating Black cohosh extract for moderate-to-severe menopausal symptoms, sponsored by Navamindradhiraj Univer…
-
CLINICAL_TRIALS trial_result · 2014-09-23Clinical Trial Update: Homeopathic Treatment for Depression in Peri- and Postmenopausal Women [Phase 2]
Phase 2 clinical trial evaluating homeopathic treatment for moderate depression in peri- and postmenopausal women; the study completed and r…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor [Phase 4]
Phase 4 clinical trial evaluating whether preoperative estrogen treatment affects connective tissues of the pelvic floor in women with pelvi…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation [NA]
Completion update for the MsFLASH-02 trial, a 3-by-2 factorial study evaluating yoga, physical exercise, and omega-3 supplementation for rel…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal Symptoms [NA]
MsFLASH-03 reports results comparing low-dose estradiol and venlafaxine XR for menopausal hot flashes and vasomotor symptoms; results were p…
-
FDA approval · 2014-07-31FDA Approved: VIVELLE-DOT — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for VIVELLE-DOT (estradiol) from Sandoz Inc., updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Effects of Yoga on Menopausal Symptoms in Women With Breast Cancer [NA]
A completed clinical trial evaluating the effects of yoga on menopausal symptoms in women with breast cancer.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study
The REVERT study evaluated relief of vasomotor symptoms with bioidentical hormone replacement therapy in menopause; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-30Clinical Trial Update: Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013) [Phase 3]
Phase 3 dose-finding trial assessing safety and efficacy of Org 50081 (Esmirtazapine) for vasomotor symptoms in postmenopausal menopause; st…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints [Phase 3]
A Phase 3 clinical trial comparing Klimadynon to conjugated estrogens for menopausal complaints has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012) [Phase 3]
Phase 3 dose-finding trial of Org50081 (Esmirtazapine) for vasomotor symptoms in menopause completed; results posted in 2014.
-
CLINICAL_TRIALS research · 2014-06-26Clinical Trial Update: Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis [Phase 1]
Phase 1 trial comparing two vaginal tablet formulations produced at different sites in postmenopausal women with atrophic vaginitis. Sponsor…
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: A Comparison of Farabloc Fabric With Placebo on Alleviation Hot Flash in Menopausal Women [NA]
This clinical trial update reports on a study comparing Farabloc fabric to placebo for reducing hot flashes in menopausal women. The current…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Safety and Efficacy of Dr. Tagliaferri's Menopause Formula [Phase 2]
Phase 2 trial completed evaluating the safety and efficacy of Dr. Tagliaferri's Menopause Formula for hot flashes associated with menopause.